Breast cancer risk and possible mechanisms of radiation-induced genomic instability in the Swedish hemangioma cohort after reanalyzed dosimetry

被引:26
|
作者
Eidemueller, Markus [1 ]
Holmberg, Erik [2 ]
Jacob, Peter [1 ]
Lundell, Marie [3 ,4 ]
Karlsson, Per [2 ]
机构
[1] Helmholtz Zentrum Munchen, Inst Radiat Protect, D-85764 Neuherberg, Germany
[2] Sahlgrens Univ Hosp, Dept Oncol, SE-41345 Gothenburg, Sweden
[3] Karolinska Univ Hosp, Dept Med Phys & Oncol, SE-17176 Stockholm, Sweden
[4] Karolinska Inst, SE-17176 Stockholm, Sweden
关键词
Breast cancer risk; Models of carcinogenesis; Radiation-induced genomic instability; ATOMIC-BOMB SURVIVORS; IONIZING-RADIATION; POOLED ANALYSIS; SOLID CANCER; COLON-CANCER; CARCINOGENESIS; MODEL; EXPOSURE; MICROENVIRONMENT; RADIOTHERAPY;
D O I
10.1016/j.mrfmmm.2015.03.002
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The cohort of 17,200 female Swedish hemangioma patients, who had been exposed to ionizing radiation because of skin hemangioma, was analyzed for breast cancer incidence with descriptive excess relative risk models and mechanistic models of carcinogenesis. The dosimetry system has recently been updated, leading to substantially reduced doses for the most highly exposed part of the Stockholm cohort. The follow-up includes persons until December 2009 with 877 breast cancer cases. All models agree on the risk estimates. The excess relative and excess absolute risk at the age of 50 years are 0.48 Gy(-1) (95% CI 0.28; 0.69) and 10.4 (10(4) PYR Gy)(-1) (95% CI 6.1; 14.4), respectively. These risk estimates are about a factor of 2 higher than previous analyses of this cohort as a consequence of the re-evaluation of the dosimetry system. Explicit models incorporating effects of genomic instability were developed and applied to the hemangioma cohort. It was found that a radiation-induced transition towards genomic instability was highly significant. The models indicate that the main effect of radiation-induced genomic instability is to increase the rate of transition of non-initiated cells to initiated cells with a proliferative advantage. The magnitude of such an acceleration cannot be inferred from epidemiological data alone, but must be complemented by radiobiological measurements. (C) 2015 The Authors. Published by Elsevier B.V.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [11] Quantitative proteomic analysis of mitochondrial proteins reveals prosurvival mechanisms in the perpetuation of radiation-induced genomic instability
    Thomas, Stefani N.
    Waters, Katrina M.
    Morgan, William F.
    Yang, Austin J.
    Baulch, Janet E.
    FREE RADICAL BIOLOGY AND MEDICINE, 2012, 53 (03) : 618 - 628
  • [12] Radiation-induced Pulmonary Toxicity and Related Risk Factors in Breast Cancer
    Kim, Hak Jae
    Jang, Won Il
    Kim, Tae Jung
    Kim, Jee Hyun
    Kim, Sung Won
    Moon, Sung Ho
    Kim, Jae Sung
    Kim, In Ah
    JOURNAL OF BREAST CANCER, 2009, 12 (02) : 67 - 72
  • [13] Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma
    Opstal-van Winden, Annemieke W. J.
    de Haan, Hugoline G.
    Hauptmann, Michael
    Schmidt, Marjanka K.
    Broeks, Annegien
    Russell, Nicola S.
    Janus, Cecile P. M.
    Krol, Augustinus D. G.
    van der Baan, Frederieke H.
    De Bruin, Marie L.
    van Eggermond, Anna M.
    Dennis, Joe
    Anton-Culver, Hoda
    Haiman, Christopher A.
    Sawyer, Elinor J.
    Cox, Angela
    Devilee, Peter
    Hooning, Maartje J.
    Peto, Julian
    Couch, Fergus J.
    Pharoah, Paul
    Orr, Nick
    Easton, Douglas F.
    Aleman, Berthe M. P.
    Strong, Louise C.
    Bhatia, Smita
    Cooke, Rosie
    Robison, Leslie L.
    Swerdlow, Anthony J.
    van Leeuwen, Flora E.
    BLOOD, 2019, 133 (10) : 1130 - 1139
  • [14] Radiation-induced lung injury after breast cancer treatment: incidence in the CANTO-RT cohort and associated clinical and dosimetric risk factors
    Gueiderikh, Anna
    Sarrade, Thomas
    Kirova, Youlia
    De La Lande, Brigitte
    De Vathaire, Florent
    Auzac, Guillaume
    Martin, Anne Laure
    Everhard, Sibille
    Meillan, Nicolas
    Bourgier, Celine
    Benyoucef, Ahmed
    Lacornerie, Thomas
    Pasquier, David
    Racadot, Severine
    Moignier, Alexandra
    Paris, Francois
    Andre, Fabrice
    Deutsch, Eric
    Duchemann, Boris
    Allodji, Rodrigue Setcheou
    Rivera, Sofia
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [15] Thyroid function following radiation therapy in breast cancer patients: risk of radiation-induced hypothyroidism
    Farshchian, Negin
    Amirifard, Nasrin
    Azar, Mohammad Hosein Saiedian
    Heydarheydari, Sahel
    Farshchian, Nazanin
    Haghparast, Abbas
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2022, 27 (04) : 691 - 698
  • [16] Out-of-Field Dose Measurement by TLD Dosimetry and Estimation of Radiation-Induced Secondary Cancer Risk of Thyroid and Breast from Head Radiotherapy
    Rahbar Yazdi S.
    Zare M.H.
    Broomand M.A.
    Journal of Biomedical Physics and Engineering, 2023, 13 (05) : 403 - 410
  • [17] Radiation-Induced Complications after Breast Cancer Radiation Therapy: a Pictorial Review of Multimodality Imaging Findings
    Yi, Ann
    Kim, Hak Hee
    Shin, Hee Jung
    Huh, Mi Ock
    Do Ahn, Seung
    Seo, Bo Kyeong
    KOREAN JOURNAL OF RADIOLOGY, 2009, 10 (05) : 496 - 507
  • [18] Radiation-induced risk of ischemic heart disease following breast cancer radiotherapy in Denmark, 1977-2005
    Lorenzen, Ebbe Laugaard
    Rehammar, Jens Christian
    Jensen, Maj-Britt
    Ewertz, Marianne
    Brink, Carsten
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : 103 - 110
  • [19] Metformin reduces radiation-induced cardiac toxicity risk in patients having breast cancer
    Yu, Jung-Min
    Hsieh, Mao-Chih
    Qin, Lei
    Zhang, Jiaqiang
    Wu, Szu-Yuan
    AMERICAN JOURNAL OF CANCER RESEARCH, 2019, 9 (05): : 1017 - 1026
  • [20] CD24-/low stem-like breast cancer marker defines the radiation-resistant cells involved in memorization and transmission of radiation-induced genomic instability
    Bensimon, J.
    Altmeyer-Morel, S.
    Benjelloun, H.
    Chevillard, S.
    Lebeau, J.
    ONCOGENE, 2013, 32 (02) : 251 - 258